| Issue Date | Title | Author(s) |
| 2015 | Complex of C₆₀ fullerene with doxorubicin as a promising agent in antitumor therapy | Prylutska, S. V.; Skivka, L. M.; Didenko, G. V.; Prylutskyy, Y. I.; Evstigneev, M. P. |
| 2014 | C₆₀ fullerene as synergistic agent in tumor-inhibitory doxorubicin treatment | Prylutska, S. V.; Grynyuk, I.; Matyshevska, O.; Prylutskyy, Y.; Evstigneev, M. P. |
| 2018 | Experimental approaches to the assessment of potential cardioprotective means with doxorubicin-associated cardiomyopathy | Danilenko, L. M.; Pokrovskiy, M. V.; Kotelnikova, A. S.; Timokhina, A. S.; Zhernakova, N. I. |
| 2024 | Novel derivative of nicotinic acid ameliorates doxorubicin-induced cardiac injury via regulation of redox homeostasis | Loboda, Ya. V.; Korokin, M. V.; Kuznetsov, A. V.; Malorodova, T. N.; Danilenko, A. P. |
| 2023 | Pharmacotherapy of small cell lung cancer: Current state-of-the-art | Berezhnova, T. A.; Lunyova, Y. A.; Dyadina, K. S.; Borisov, V. A. |
| 2017 | Study of dose-dependent effect of 2-ethyl-6-methyl-3 hydroxypyridine succinate on the contractile function of isolated rat heat | Kesarev, O. G.; Danilenko, L. M.; Pokrovskii, M. V.; Timokhina, A. S.; Khavanskii, A. V. |
| 2018 | Study of the properties of doxorubicin-resistant cells affected by acute leucosis | Skorkina, M. Yu.; Shamray, E. A.; Salo, V. A.; Buchelnikov, A. S.; Evstigneev, M. P. |
